FDA Approves New Ready-to-Use Convenia Injection

Zoetis has received FDA approval for a new, more concentrated, ready-to-use version of Convenia injection, according to Myvetcandy. The formulation delivers up to 14 days of antibiotic treatment in a single injection.

Myvetcandy reported that the new version could make management of bacterial skin infections easier for veterinarians and dog owners. The publisher specifically identified larger dogs as a setting where the updated formulation may be helpful.

What FDA approved

The approved product is a new Convenia injection formulation from Zoetis, Myvetcandy said. It is more concentrated and ready to use.

According to Myvetcandy, a single injection can provide up to 14 days of antibiotic treatment. The report connects the product to management of bacterial skin infections in dogs.

The announcement focuses on the combination of concentration, ready-to-use presentation, and treatment duration from one injection. Myvetcandy characterized the formulation as an update that could make treatment management easier in the situations it described.

Context for veterinary teams

Myvetcandy said the formulation could support veterinarians and dog owners managing bacterial skin infections. Its report also highlighted larger dogs, noting that the new injection could make treatment easier when larger dogs need treatment.

For veterinary and animal-health sales professionals, the event is an FDA approval involving a new Convenia presentation. Discussions can remain grounded in the details reported by Myvetcandy: a more concentrated, ready-to-use injection that delivers up to 14 days of antibiotic treatment in a single injection.

The publisher’s report does not expand beyond this product update, its FDA approval, and its potential relevance to management of bacterial skin infections in dogs. Veterinary teams evaluating the announcement can distinguish the reported formulation details from broader clinical considerations not addressed in the report.

Reported source details

Myvetcandy reported the FDA approval of Zoetis’ new Convenia injection on October 22, 2026. The report describes the product as a more concentrated, ready-to-use version of Convenia and identifies its single-injection delivery of up to 14 days of antibiotic treatment.